Cargando…

Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome

BACKGROUND: Exposure to Epstein-Barr virus (EBV) infection has been hypothesized to be an important risk factor for multiple rheumatic diseases, but the serological evidence so far for its role in Sjögren’s syndrome (SjS) is not clearly established yet. This study aimed to assess the seroepidemiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Xuan, Jingxiu, Ji, Zhiqian, Wang, Bin, Zeng, Xiaoli, Chen, Rongjuan, He, Yan, Rao, Peishi, Wu, Puqi, Shi, Guixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662096/
https://www.ncbi.nlm.nih.gov/pubmed/33193425
http://dx.doi.org/10.3389/fimmu.2020.590444
_version_ 1783609328827105280
author Xuan, Jingxiu
Ji, Zhiqian
Wang, Bin
Zeng, Xiaoli
Chen, Rongjuan
He, Yan
Rao, Peishi
Wu, Puqi
Shi, Guixiu
author_facet Xuan, Jingxiu
Ji, Zhiqian
Wang, Bin
Zeng, Xiaoli
Chen, Rongjuan
He, Yan
Rao, Peishi
Wu, Puqi
Shi, Guixiu
author_sort Xuan, Jingxiu
collection PubMed
description BACKGROUND: Exposure to Epstein-Barr virus (EBV) infection has been hypothesized to be an important risk factor for multiple rheumatic diseases, but the serological evidence so far for its role in Sjögren’s syndrome (SjS) is not clearly established yet. This study aimed to assess the seroepidemiological associations of antibodies to EBV with SjS. METHODS: A seroepidemiological study containing 119 patients with SjS and 65 healthy controls was first performed, in which the associations of SjS with four commonly studied EBV antibodies including IgM-anti-viral capsid antigen (anti-VCA) antibody, IgG-anti-VCA antibody, IgG-anti-early antigen (anti-EA) antibody, and IgG-anti-EBV nuclear antigen 1 (anti-EBNA1) antibody were evaluated. A systematic review and meta-analysis of eligible seroepidemiological studies was also carried out, and data syntheses were performed using random-effect meta-analysis. RESULTS: In the case-control study, the patients with SjS had both a significantly higher prevalence of IgG-anti-EA antibody positivity (31.9% vs. 3.1%, P < 0.001) and high titers of IgG-anti-EA antibody (P < 0.001) than healthy controls. The titer of IgG-anti-VCA antibody was significantly increased in the patients with SjS compared with healthy controls (P < 0.001). IgG-anti-EA antibody seropositive patients with SjS had lower levels of both C3 (P = 0.002) and C4 (P = 0.02), and the titer of IgG-anti-EA antibody was inversely related to the levels of both C3 (r = -0.31, P < 0.001) and C4 (r = -0.20, P = 0.03). A total of 14 eligible studies on the serological associations between EBV infection and SjS were finally included into the meta-analysis, which suggested obvious associations of SjS with IgM-anti-VCA antibody [Odds ratio (OR) = 5.77, 95%CI 1.73–19.25, P = 0.004] and IgG-anti-EA antibody (OR = 9.97, 95%CI 4.58-21.67, P < 0.00001). CONCLUSIONS: The findings from this study provide strong serological evidence for the association between EBV infection and SjS. SjS has obvious associations with IgM-anti-VCA antibody and IgG-anti-EA antibody. IgG-anti-EA antibody is linked to low levels of C3 and C4 in the patients with SjS, the significance of which needs to be addressed in further studies.
format Online
Article
Text
id pubmed-7662096
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76620962020-11-13 Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome Xuan, Jingxiu Ji, Zhiqian Wang, Bin Zeng, Xiaoli Chen, Rongjuan He, Yan Rao, Peishi Wu, Puqi Shi, Guixiu Front Immunol Immunology BACKGROUND: Exposure to Epstein-Barr virus (EBV) infection has been hypothesized to be an important risk factor for multiple rheumatic diseases, but the serological evidence so far for its role in Sjögren’s syndrome (SjS) is not clearly established yet. This study aimed to assess the seroepidemiological associations of antibodies to EBV with SjS. METHODS: A seroepidemiological study containing 119 patients with SjS and 65 healthy controls was first performed, in which the associations of SjS with four commonly studied EBV antibodies including IgM-anti-viral capsid antigen (anti-VCA) antibody, IgG-anti-VCA antibody, IgG-anti-early antigen (anti-EA) antibody, and IgG-anti-EBV nuclear antigen 1 (anti-EBNA1) antibody were evaluated. A systematic review and meta-analysis of eligible seroepidemiological studies was also carried out, and data syntheses were performed using random-effect meta-analysis. RESULTS: In the case-control study, the patients with SjS had both a significantly higher prevalence of IgG-anti-EA antibody positivity (31.9% vs. 3.1%, P < 0.001) and high titers of IgG-anti-EA antibody (P < 0.001) than healthy controls. The titer of IgG-anti-VCA antibody was significantly increased in the patients with SjS compared with healthy controls (P < 0.001). IgG-anti-EA antibody seropositive patients with SjS had lower levels of both C3 (P = 0.002) and C4 (P = 0.02), and the titer of IgG-anti-EA antibody was inversely related to the levels of both C3 (r = -0.31, P < 0.001) and C4 (r = -0.20, P = 0.03). A total of 14 eligible studies on the serological associations between EBV infection and SjS were finally included into the meta-analysis, which suggested obvious associations of SjS with IgM-anti-VCA antibody [Odds ratio (OR) = 5.77, 95%CI 1.73–19.25, P = 0.004] and IgG-anti-EA antibody (OR = 9.97, 95%CI 4.58-21.67, P < 0.00001). CONCLUSIONS: The findings from this study provide strong serological evidence for the association between EBV infection and SjS. SjS has obvious associations with IgM-anti-VCA antibody and IgG-anti-EA antibody. IgG-anti-EA antibody is linked to low levels of C3 and C4 in the patients with SjS, the significance of which needs to be addressed in further studies. Frontiers Media S.A. 2020-10-30 /pmc/articles/PMC7662096/ /pubmed/33193425 http://dx.doi.org/10.3389/fimmu.2020.590444 Text en Copyright © 2020 Xuan, Ji, Wang, Zeng, Chen, He, Rao, Wu and Shi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Xuan, Jingxiu
Ji, Zhiqian
Wang, Bin
Zeng, Xiaoli
Chen, Rongjuan
He, Yan
Rao, Peishi
Wu, Puqi
Shi, Guixiu
Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title_full Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title_fullStr Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title_full_unstemmed Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title_short Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
title_sort serological evidence for the association between epstein-barr virus infection and sjögren’s syndrome
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662096/
https://www.ncbi.nlm.nih.gov/pubmed/33193425
http://dx.doi.org/10.3389/fimmu.2020.590444
work_keys_str_mv AT xuanjingxiu serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT jizhiqian serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT wangbin serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT zengxiaoli serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT chenrongjuan serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT heyan serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT raopeishi serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT wupuqi serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome
AT shiguixiu serologicalevidencefortheassociationbetweenepsteinbarrvirusinfectionandsjogrenssyndrome